Bausch + Lomb Corporation (BLCO)
17.18
+0.25 (1.48%)
Upcoming Events
Latest Headlines
Form 8-K Bausch & Lomb Corp For: Oct 11
October 13, 2026 6:10 AM - SEC Filing
Bausch + Lomb names Appio interim CEO as Saunders departs
October 12, 2026 6:46 AM - StreetInsider
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
October 12, 2026 6:45 AM - BizWire
RBC Capital on Bausch & Lomb Corp. (BLCO): 'Rx DED momentum drives estimates higher'
October 8, 2026 8:04 AM - StreetInsider
Bausch + Lomb eyes 2027 trial start for oral dry AMD drug
October 6, 2026 4:30 PM - StreetInsider
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting
October 6, 2026 4:30 PM - BizWire
Barclays Starts Bausch & Lomb Corp. (BLCO) at Overweight
October 6, 2026 4:25 PM - StreetInsider
Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28
October 5, 2026 7:30 AM - BizWire
Bausch + Lomb gets EU approval for SeeLyra femtosecond laser
September 11, 2026 6:11 AM - StreetInsider
Bausch + Lomb Announces European CE Mark Approval of SeeLyra™ Femtosecond Laser
September 11, 2026 6:11 AM - BizWire
Leerink Starts Bausch & Lomb Corp. (BLCO) at Outperform
September 9, 2026 6:21 AM - StreetInsider
Bausch + Lomb publishes real-world study on enVista Aspire lenses
September 2, 2026 7:01 AM - StreetInsider
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
September 2, 2026 7:00 AM - BizWire
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
September 1, 2026 6:58 AM - BizWire
H.C. Wainwright Reiterates Buy Rating on Bausch & Lomb Corp. (BLCO)
August 28, 2026 7:04 AM - StreetInsider
Bausch & Lomb Corp. (BLCO) Reiterated at Hold by Stifel on Mixed Ph2 Data for Xiidra+Miebo
August 25, 2026 7:08 AM - StreetInsider
Bausch + Lomb advances two eye drop candidates to new trials
August 24, 2026 4:30 PM - StreetInsider
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
August 24, 2026 4:30 PM - BizWire
Form 4 Bausch & Lomb Corp For: Aug 12 Filed by: Trebbi Barbara
August 14, 2026 5:48 PM - SEC Filing
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: Trebbi Barbara
August 14, 2026 5:45 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 12 Filed by: PAUL LAURENCE E
August 14, 2026 5:35 PM - SEC Filing
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: PAUL LAURENCE E
August 14, 2026 5:33 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 12 Filed by: Chersi Robert J
August 14, 2026 5:26 PM - SEC Filing
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: Chersi Robert J
August 14, 2026 5:23 PM - SEC Filing
Form 3 Bausch & Lomb Corp For: Aug 05 Filed by: APPIO THOMAS
August 14, 2026 5:10 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 10 Filed by: Munsch Frederick
August 12, 2026 7:06 PM - SEC Filing
Bausch + Lomb names Appio as chairman, reshapes board committees
August 12, 2026 7:03 AM - StreetInsider
Form 4 Bausch & Lomb Corp For: Aug 06 Filed by: VON ESCHENBACH ANDREW C.
August 10, 2026 8:58 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Stewart Andrew J.
August 7, 2026 4:55 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Munsch Frederick
August 7, 2026 4:53 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Hashad Yehia
August 7, 2026 4:51 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Eldessouky Sam
August 7, 2026 4:42 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Bonnefoy Luc
August 7, 2026 4:35 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: Bailey A Robert D
August 7, 2026 4:33 PM - SEC Filing
Form 4 Bausch & Lomb Corp For: Aug 05 Filed by: SAUNDERS BRENT L
August 7, 2026 4:31 PM - SEC Filing
Bausch Health CEO joins Bausch + Lomb board amid reshuffle
August 6, 2026 7:05 AM - StreetInsider
Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board
August 6, 2026 7:04 AM - PR NewsWire
Bausch + Lomb adds four directors, reaffirms 2026 guidance
August 6, 2026 7:01 AM - StreetInsider
Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance
August 6, 2026 7:00 AM - BizWire
Bausch & Lomb Corp. (BLCO) PT Raised to $21 at H.C. Wainwright
August 3, 2026 6:56 AM - StreetInsider
Bausch & Lomb Corp. (BLCO) PT Raised to $23 at UBS
July 30, 2026 9:29 AM - StreetInsider
BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
July 29, 2026 4:05 PM - PR NewsWire
Bausch + Lomb Corporation (BLCO) Reports In-Line Q2 EPS, Beats on Revenue; Offers FY26 Revenue Guidance
July 29, 2026 6:59 AM - StreetInsider
Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance
July 29, 2026 6:58 AM - BizWire
UBS Starts Bausch & Lomb Corp. (BLCO) at Buy
July 28, 2026 6:25 AM - StreetInsider
Full Article List
